Biblio Discovery — Demo Discovery Service

451 results for "Mohan, Viswanathan"

Showing 1–20 · 1.06 seconds · RSS

  1. Journal Article Full text

    My 40-year journey in diabetes research: The power of collaboration

    Mohan, Viswanathan

    Perspect Clin Res · 2018 · English · PubMed Central

    This article describes a 40 year journey in diabetes research of an Indian diabetologist, starting as an undergraduate medical student. The article describes how collaborations with multiple stake-holders is necessary if one is to advance one's research from the simple studies that one starts with…

  2. Journal Article Full text

    COVID-19 and Diabetes—A View From India

    Mohan, Viswanathan

    J Diabetes Sci Technol · 2020 · English · PubMed Central

  3. Journal Article Full text

    Lessons Learned From Epidemiology of Type 2 Diabetes in South Asians: Kelly West Award Lecture 2024

    Mohan, Viswanathan

    Diabetes Care · 2025 · English · PubMed Central

    South Asia has high prevalence rates of type 2 diabetes (T2D). Until the 1990s, the prevalence of T2D within South Asia was low but much higher in the South Asian diaspora living abroad. Today, high prevalence rates of T2D are reported among those living in South Asia. T2D in South Asians presents…

  4. Journal Article Full text

    Challenges in Estimation of Glycated Hemoglobin in India

    Unnikrishnan, Ranjit; Mohan, Viswanathan

    Diabetes Technol Ther · 2013 · English · PubMed Central

    Glycated hemoglobin (HbA1c) is the most widely accepted index of long-term glycemic control. However, there are some clinical situations that make the accurate measurement of HbA1c difficult. Although some of these situations are general, others are more specific to some parts of the world like…

  5. Journal Article Full text

    Pros & cons of some popular extreme weight-loss diets

    Joshi, Shilpa; Mohan, Viswanathan

    Indian J Med Res · 2018 · English · PubMed Central

    Obesity has now become a huge public health issue not only in the developed world but also in developing countries. In view of the health hazards associated with obesity and more importantly for cosmetic reasons, many people, particularly the youth, have started resorting to ‘extreme’ weight-loss…

  6. Journal Article Full text

    Precision diabetes: Where do we stand today?

    Mohan, Viswanathan; Unnikrishnan, Ranjit

    Indian J Med Res · 2018 · English · PubMed Central

  7. Journal Article Full text

    Precision Diabetes Is Slowly Becoming a Reality

    Mohan, Viswanathan; Radha, Venkatesan

    Med Princ Pract · 2019 · English · PubMed Central

    The concept of precision medicine is becoming increasingly popular. The use of big data, genomics and other “omics” like metabolomics, proteomics and transcriptomics could make the dream of personalised medicine become a reality in the near future. As far as polygenic forms of diabetes like type 2…

  8. Journal Article Full text

    Ketogenic diets: Boon or bane?

    Shilpa, Joshi; Mohan, Viswanathan

    Indian J Med Res · 2018 · English · PubMed Central

  9. Journal Article Full text

    Epidemiology of type 2 diabetes in India

    Pradeepa, Rajendra; Mohan, Viswanathan

    Indian J Ophthalmol · 2021 · English · PubMed Central

    The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to…

  10. Journal Article Full text

    Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring

    Kesavadev, Jothydev; Mohan, Viswanathan

    J Indian Inst Sci · 2023 · English · PubMed Central

    The effect of an increasing diabetes population has resulted in escalated costs and overburdened physicians. The increase in cost is not due to the disease per se, but because of its largely preventable complications. Patient-friendly technologies are proven to significantly reduce complications…

  11. Journal Article Full text

    Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice

    Mohan, Viswanathan; Anbalagan, Viknesh Prabu

    Indian J Endocrinol Metab · 2013 · English · PubMed Central

    The Indian Diabetes Risk Score was initially developed by the Madras Diabetes Research Foundation (MDRF-IDRS) to help detect undiagnosed Type 2 diabetes (T2DM) in the community. Soon it was found that the MDRF-IDRS could also help to predict incident diabetes, metabolic syndrome, coronary artery…

  12. Journal Article Full text

    Changing definitions of metabolic syndrome

    Parikh, Rakesh M.; Mohan, Viswanathan

    Indian J Endocrinol Metab · 2012 · English · PubMed Central

    The first description of patients with clustering of various metabolic abnormalities was as early as 1923 but it was more than five decades later, in 1988, that Reaven coined the term ‘syndrome X’ for this entity. The last two decades have brought forth a number of definitions and criteria to…

  13. Journal Article

    Genes and diabetic retinopathy.

    Radha Venkatesan; Rema Mohan; Mohan Viswanathan

    Indian Journal of Ophthalmology, Vol. 50 No. 1 · 2002 · English · DOAJ Scopus

    Several recent studies have provided evidence that good diabetes control is important to prevent diabetic retinopathy. However, some groups of patients develop diabetic retinopathy despite good control and others escape retinopathy despite poor control. This suggests the role of genetic factors in…

  14. Journal Article Full text

    High Sensitivity C-Reactive Protein, Tumor Necrosis Factor-α, Interleukin-6, and Vascular Cell Adhesion Molecule-1 Levels in Asian Indians with Metabolic Syndrome and Insulin Resistance (CURES-105)

    Indulekha, Karunakaran; Surendar, Jayagopi; Mohan, Viswanathan

    J Diabetes Sci Technol · 2011 · English · PubMed Central

    AIM: The aim of this study was to assess levels of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and vascular cell adhesion molecule-1 (VCAM-1) in South Indian subjects with and without MS and among MS subjects with and without insulin…

  15. Journal Article Full text

    Does tight control of systemic factors help in the management of diabetic retinopathy?

    Rajalakshmi, Ramachandran; Prathiba, Vijayaraghavan; Mohan, Viswanathan

    Indian J Ophthalmol · 2016 · English · PubMed Central

    Diabetic retinopathy (DR), one of the leading causes of preventable blindness, is associated with many systemic factors that contribute to the development and progression of this microvascular complication of diabetes. While the duration of diabetes is the major risk factor for the development of…

  16. Journal Article Full text

    Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience

    Pradeepa, Rajendra; Nazir, Adamsha; Mohan, Viswanathan

    Heart Asia · 2012 · English · PubMed Central

    In India, diabetes and cardiovascular disease (CVD) are growing health problems. CVD accounts for much of the increased morbidity and premature mortality associated with type 2 diabetes. Moreover, CVD also occurs 2–3 decades earlier among diabetic subjects and runs a more aggressive course and has…